Advertisement · 728 × 90
#
Hashtag
#Zuranolone
Advertisement · 728 × 90
Preview
BPS Publications Sage, in collaboration with Biogen, submitted a new drug approval for zuranolone for postpartum depression (PPD) and major depressive disorder (MDD) in December 2022. In August 2023, the US Food and ...

A critical review of how (we think) #zuranolone, a treatment for #postpartumdepression was rushed through the #FDA, resulting in cut corners that allowed its marketing without much evidence of benefit. #medsky bpspubs.onlinelibrary.wiley.com/doi/10.1002/...

0 0 0 0
Preview
Health Canada approves 1st pill to treat postpartum depression Health Canada has approved the first drug designed to treat postpartum depression.

" #Zuranolone is a welcome drug for women suffering from moderate to severe #postpartumdepression, said Dr. Crystal Clark, #Canada Research Chair in reproductive #mentalhealth and a psychiatrist at Women’s College Hospital in #Toronto" www.ctvnews.ca/health/artic...

0 0 0 0
Post image

😞 L'administration de #brexanolone et de #zuranolone peut‐elle aider les femmes qui souffrent de #dépression #postpartum ?

📚 Revue @cochrane.org (6 ECR 674 personnes)

🔗 t.ly/y1LV7

#santé #santémentale #accouchement #dpp #santédelafemme #médecine #antidépresseurs #gabaa #neurostéroïdes

0 0 0 0
Preview
UK’s first oral treatment for postnatal depression approved by MHRA Zuranolone has become the first oral treatment for postnatal depression (PND) to be approved for the UK by the MHRA

UK’s first oral treatment for postnatal depression approved by MHRA

buff.ly/woPHizT

#pharmacy #UKpharmacy #MHRA #zuranolone #postnatal #depression

0 0 0 0
Preview
UK’s first oral treatment for postnatal depression approved by MHRA Zuranolone has become the first oral treatment for postnatal depression (PND) to be approved for the UK by the MHRA

UK’s first oral treatment for postnatal depression approved by MHRA

buff.ly/woPHizT

#pharmacy #UKpharmacy #MHRA #zuranolone #postnatal #depression

0 0 0 0
Preview
Della Vedova family funds promising study on repurposing zuranolone for Parkinson’s - Parkinson Canada Professor Denis Soulet at Université Laval is leading a groundbreaking investigation into whether a medication currently used to treat postpartum depression could also protect the brain in Parkinson’s...

With support from the Della Vedova family, Prof. Denis Soulet at @ulaval.ca is exploring whether #zuranolone, a medication for postpartum depression, may help protect dopamine-producing neurons in #Parkinson’s.

Read more 👉 www.parkinson.ca/della-vedova...

#ParkinsonsResearch

0 1 0 0
Preview
What to Know About Zurzuvae, the New Pill to Treat Postpartum Depression The FDA recently approved zuranolone, the first-ever oral medication to treat postpartum depression (PPD). A Yale psychiatrist answers questions about the new drug.

www.yalemedicine.org/news/postpar...
@dynavox.bsky.social 🦄
No worries 🩷
#Zuranolone is a synthetic form of allopregnanolone, a naturally occurring neurosteroid that the body makes from the hormone progesterone. Allopregnanolone helps the GABA-A receptors, which regulate mood and behavior…”

0 0 0 0
Preview
Efficacy and tolerability of zuranolone in patients with depression: a meta-analysis of randomized c... Background: As a novel antidepressant drug, zuranolone has been initially applied in treating depression. This study investigated the efficacy and safety of its administration in patients with depress...

On comparison of different dosages, the 30 mg dose showed significantly greater efficacy than 20 mg dose. The absence of any deaths or significant adverse effects among the 1884 patients #zuranolone was well-tolerated during administration…

www.frontiersin.org/articles/10....

0 0 0 0
Characteristics and outcome measures of the included trials.

Characteristics and outcome measures of the included trials.

MedSky🧪 #NeuroSky #Mentaldisorders Based on the analysis of existing clinical trials, #zuranolone appears to demonstrate a rapid-onset short-term effect along with a definite sustained effect in #depression. Subgroup analysis also confirmed its efficacy in MDD and PPD

0 0 1 0
Post image

In a field where men are the default and female aspects under-researched, it’s no surprise that postpartum depression—happening to 1 in 7 women—hasn’t been treatable with a simple pill. Until now. Progress happens. #FeministFriday #GenderEquality #PPD #zuranolone #zurzuvae #research

3 1 0 0